These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9302778)
1. [Current prospects of specific treatment of Chagas' disease]. Coura JR Bol Chil Parasitol; 1996; 51(3-4):69-75. PubMed ID: 9302778 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina]. Sosa Estani S; Segura EL Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259 [TBL] [Abstract][Full Text] [Related]
4. Current status of Chagas disease chemotherapy. Guedes PM; Silva GK; Gutierrez FR; Silva JS Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270 [TBL] [Abstract][Full Text] [Related]
5. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Castro JA; de Mecca MM; Bartel LC Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919 [TBL] [Abstract][Full Text] [Related]
6. [Chagas' disease and its significance for Central and South America (author's transl)]. Berning H MMW Munch Med Wochenschr; 1981 Jan; 123(1):23-6. PubMed ID: 6780884 [TBL] [Abstract][Full Text] [Related]
7. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164 [TBL] [Abstract][Full Text] [Related]
9. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease). Castro JA; Diaz de Toranzo EG Biomed Environ Sci; 1988 Jun; 1(1):19-33. PubMed ID: 3151755 [TBL] [Abstract][Full Text] [Related]
10. [Part VI. Antiparasitic treatment for Chagas disease]. B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Rassi A; Dias JC; Marin-Neto JA; Rassi A Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444 [TBL] [Abstract][Full Text] [Related]
13. Early nifurtimox-induced biochemical and ultrastructural alterations in rat heart. Bartel LC; Montalto de Mecca M; Fanelli SL; Rodriguez de Castro C; Diaz EG; Castro JA Hum Exp Toxicol; 2007 Oct; 26(10):781-8. PubMed ID: 18025049 [TBL] [Abstract][Full Text] [Related]
14. [Nifurtimox treatment of chronic Chagasic infection in children]. Schenone H; Contreras M; Solari A; García A; Rojas A; Lorca M Rev Med Chil; 2003 Sep; 131(9):1089-90. PubMed ID: 14635599 [No Abstract] [Full Text] [Related]
18. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
19. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Sosa-Estani S; Segura EL Curr Opin Infect Dis; 2006 Dec; 19(6):583-7. PubMed ID: 17075335 [TBL] [Abstract][Full Text] [Related]
20. Chagas' disease reactivation with skin symptoms in a patient with kidney transplant. Gallerano V; Consigli J; Pereyra S; Gómez Zanni S; Danielo C; Gallerano RH; Guidi A Int J Dermatol; 2007 Jun; 46(6):607-10. PubMed ID: 17550560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]